Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8802

1.

Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities.

Estrada CC, Maldonado A, Mallipattu SK.

J Am Soc Nephrol. 2019 Jan 14. pii: ASN.2018080853. doi: 10.1681/ASN.2018080853. [Epub ahead of print] Review.

PMID:
30642877
2.

Manipulation of Nephron-Patterning Signals Enables Selective Induction of Podocytes from Human Pluripotent Stem Cells.

Yoshimura Y, Taguchi A, Tanigawa S, Yatsuda J, Kamba T, Takahashi S, Kurihara H, Mukoyama M, Nishinakamura R.

J Am Soc Nephrol. 2019 Jan 11. pii: ASN.2018070747. doi: 10.1681/ASN.2018070747. [Epub ahead of print]

PMID:
30635375
3.

Producing Purer Podocytes.

Freedman BS.

J Am Soc Nephrol. 2019 Jan 11. pii: ASN.2018101045. doi: 10.1681/ASN.2018101045. [Epub ahead of print] No abstract available.

PMID:
30635374
4.

Hepatocyte Growth Factor-Secreting Mesothelial Cell Sheets Suppress Progressive Fibrosis in a Rat Model of CKD.

Oka M, Sekiya S, Sakiyama R, Shimizu T, Nitta K.

J Am Soc Nephrol. 2019 Jan 11. pii: ASN.2018050556. doi: 10.1681/ASN.2018050556. [Epub ahead of print]

PMID:
30635373
5.

New Insights into the Mechanism of NO3 - Selectivity in the Human Kidney Chloride Channel ClC-Ka and the CLC Protein Family.

Lagostena L, Zifarelli G, Picollo A.

J Am Soc Nephrol. 2019 Jan 11. pii: ASN.2018060593. doi: 10.1681/ASN.2018060593. [Epub ahead of print]

PMID:
30635372
6.

Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

Sadasivam M, Noel S, Lee SA, Gong J, Allaf ME, Pierorazio P, Rabb H, Hamad ARA.

J Am Soc Nephrol. 2019 Jan 8. pii: ASN.2018080815. doi: 10.1681/ASN.2018080815. [Epub ahead of print]

PMID:
30622155
7.

IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.

Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR.

J Am Soc Nephrol. 2019 Jan 8. pii: ASN.2018090901. doi: 10.1681/ASN.2018090901. [Epub ahead of print]

PMID:
30622154
8.

Lipid Peroxidation Drives Renal Cyst Growth In Vitro through Activation of TMEM16A.

Schreiber R, Buchholz B, Kraus A, Schley G, Scholz J, Ousingsawat J, Kunzelmann K.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018010039. doi: 10.1681/ASN.2018010039. [Epub ahead of print]

PMID:
30606785
9.

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

Marques IDB, Araújo MJCLN, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, Custódio MR, Jorgetti V, Elias RM, Moysés RMA, David-Neto E.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018060656. doi: 10.1681/ASN.2018060656. [Epub ahead of print]

PMID:
30606784
10.

Readmissions Metrics in Hemodialysis: Do the Specifics Matter?

Dad T, Weiner DE.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018101033. doi: 10.1681/ASN.2018101033. [Epub ahead of print] No abstract available.

PMID:
30606783
11.

Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis.

Lin E, Bhattacharya J, Chertow GM.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018080858. doi: 10.1681/ASN.2018080858. [Epub ahead of print]

PMID:
30606782
12.

Erratum.

[No authors listed]

J Am Soc Nephrol. 2019 Jan;30(1):182. doi: 10.1681/ASN.2018111096. No abstract available.

13.

Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI.

Wang Z, Salih E, Igwebuike C, Mulhern R, Bonegio RG, Havasi A, Borkan SC.

J Am Soc Nephrol. 2019 Jan;30(1):50-62. doi: 10.1681/ASN.2018040401.

PMID:
30573638
14.

Improving Clinical Outcomes in the Era of Information Ubiquity.

Califf RM.

J Am Soc Nephrol. 2019 Jan;30(1):7-12. doi: 10.1681/ASN.2018111128. No abstract available.

PMID:
30573637
15.

Simple Postoperative AKI Risk (SPARK) Classification before Noncardiac Surgery: A Prediction Index Development Study with External Validation.

Park S, Cho H, Park S, Lee S, Kim K, Yoon HJ, Park J, Choi Y, Lee S, Kim JH, Kim S, Chin HJ, Kim DK, Joo KW, Kim YS, Lee H.

J Am Soc Nephrol. 2019 Jan;30(1):170-181. doi: 10.1681/ASN.2018070757. Epub 2018 Dec 18.

PMID:
30563915
16.

Postoperative AKI-Prevention Is Better than Cure?

Bell S, Prowle J.

J Am Soc Nephrol. 2019 Jan;30(1):4-6. doi: 10.1681/ASN.2018111127. Epub 2018 Dec 18. No abstract available.

PMID:
30563914
17.

Growth of the ESKD Population: Progress or Peril?

Collins AJ.

J Am Soc Nephrol. 2019 Jan;30(1):3-4. doi: 10.1681/ASN.2018111135. Epub 2018 Dec 17. No abstract available.

PMID:
30559145
18.

Kir4.1/Kir5.1 Activity Is Essential for Dietary Sodium Intake-Induced Modulation of Na-Cl Cotransporter.

Wu P, Gao ZX, Su XT, Wang MX, Wang WH, Lin DH.

J Am Soc Nephrol. 2018 Dec 17. pii: ASN.2018080799. doi: 10.1681/ASN.2018080799. [Epub ahead of print]

PMID:
30559144
19.

Projecting ESRD Incidence and Prevalence in the United States through 2030.

McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM.

J Am Soc Nephrol. 2019 Jan;30(1):127-135. doi: 10.1681/ASN.2018050531. Epub 2018 Dec 17.

PMID:
30559143
20.

Expression Profiling of Fibroblasts in Chronic and Acute Disease Models Reveals Novel Pathways in Kidney Fibrosis.

Higashi AY, Aronow BJ, Dressler GR.

J Am Soc Nephrol. 2019 Jan;30(1):80-94. doi: 10.1681/ASN.2018060644. Epub 2018 Dec 13.

PMID:
30545984

Supplemental Content

Loading ...
Support Center